Cite
APA Citation
Vincenti, F., Budde, K., Merville, P., Shihab, F., Ram Peddi, V., Shah, M., Wyburn, K., Cassuto‐Viguier, E., Weidemann, A., Lee, M., Flegel, T., Erdman, J., Wang, X., & Lademacher, C. (2018). a randomized, phase 2 study of ASP0113, a DNA‐based vaccine, for the prevention of CMV in CMV‐seronegative kidney transplant recipients receiving a kidney from a CMV‐seropositive donor. American journal of transplantation, 18(12), 2945–2954. http://access.bl.uk/ark:/81055/vdc_100073410834.0x00001c